TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Odeum Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover | 155 | 169 | |
Financial expenses | 0 | 3 | |
Earnings before taxes | -338 | -250 | |
EBITDA | -283 | -207 | |
Total assets | 10,236 | 11,174 | |
Current assets | 7,525 | 8,367 | |
Current liabilities | 285 | 694 | |
Equity capital | 9,810 | 10,253 | |
- share capital | 72 | 73 | |
Employees (average) | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency | 95.8% | 91.8% | |
Turnover per employee | |||
Profit as a percentage of turnover | -218.1% | -147.9% | |
Return on assets (ROA) | -3.3% | -2.2% | |
Current ratio | 2640.4% | 1205.6% | |
Return on equity (ROE) | -3.4% | -2.4% | |
Change turnover | -12 | 62 | |
Change turnover % | 9% | -7% | 57% |
Chg. No. of employees | 0 | 0 | -1 |
Chg. No. of employees % | -100% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.